Anduril IPO: What We Actually Know

Anduril IPO speculation has become defense tech’s favorite parlor game, and it is easy to see why. Palmer Luckey’s company has raised over $10 billion, won a reported roughly $20 billion ten-year Army contract, and is building hyperscale manufacturing capacity in Ohio. Every pre-IPO marker an investor looks for is in place, except the one that matters most: an announced date. There isn’t one.

Banyan Hill’s Next Elon presentation, hosted by Matt Milner, is built around the space between “clearly heading public” and “not yet public,” which is where every backdoor investment story lives. Our full teardown covers the pitch. This piece sticks to the verifiable timeline.

What We Know for Certain

The funding trail is the clearest signal. Anduril has raised more than $10 billion across rounds, with tender discussions through 2025-2026 pushing reported valuations into the tens of billions and rising. Founders Fund is the lead backer, and the presentation claims Peter Thiel’s investment is “literally the largest investment in the history of Thiel’s firm.” The lead position is verified; the dollar figure is not independently confirmed.

The contract base is equally real: the Army award reported at roughly $20 billion over ten years, the Navy’s multi-billion-dollar submarine industrial base investment tied to Ghost Shark production at Arsenal-1, the IVAS headset program taken over from Microsoft, and a Roadrunner order in the hundreds of millions. Milner’s “$26 billion” contract sum is his own arithmetic across named awards, but the underlying awards are documented.

Companies do not build hyperscale manufacturing while planning to stay private forever. Arsenal-1 is the strongest structural hint that an exit path is being prepared.

There is also a talent-market signal worth noting. Anduril has recruited aggressively from both Silicon Valley and traditional defense primes, and the caliber of hires a private company can attract tends to track its expected exit horizon. None of this amounts to a date, but it does amount to momentum in one direction, which is why the IPO question keeps coming up in every serious defense-tech conversation this year.

Why the Pitch Treats the IPO as a Countdown

The presentation’s urgency runs through the pre-IPO window: “pre-IPO, where the biggest gains always have been made, and where the biggest gains always will be made.” And: “if you miss out on this you really might regret it for the rest of your life. Just like so many people regret not betting on Elon from the very beginning.”

The structural fact behind the framing is genuine: an IPO repricing ends the pre-IPO entry story. Once Anduril lists, the public buys at the public price. What the framing glosses is that the pre-IPO exposure available to ordinary investors today is limited to a fund sliver: XOVR, the ERShares Private-Public Crossover ETF, holds Anduril in a private sleeve of roughly 15% of assets, with Anduril outside the top 10. That is real exposure, modest by construction, and our full Next Elon teardown assesses the fund at length.

The Palantir Precedent

The re-rating scenario everyone is modeling is Palantir, which was 2024’s best-performing S&P 500 stock after years of trading like a slow-growth government contractor before the market re-priced it as an AI software company. The parallel is imperfect, Anduril is hardware-heavy where Palantir is software, but the pattern is the same: a defense-tech company whose public debut forces the market to decide what the technology is actually worth.

Milner’s supplier thesis leans on the same history: the companies selling into Anduril’s build-out re-rating alongside it. His three picks, a battery maker, a defense systems firm with over $3 billion in revenue, and a military chip company, are the paid content behind a $299 Grey Swan trial with a 30-day refund.

The Honest Timeline

What can be said without speculation: Anduril is private, well-capitalized, heavily contracted, and building manufacturing capacity that implies scale ambitions beyond private markets. What cannot be said: when it lists, at what valuation, or whether the supplier layer re-rates before or after. Anyone claiming a date is selling something, which is precisely the situation the Next Elon presentation monetizes with its pre-IPO framing.

For the sector context that would drive an Anduril debut, our AI defense stocks coverage and the Behind the Markets Arsenal review cover the defense-tech investment theme from two other angles.

The bottom line on the Anduril IPO: all the preconditions are visible, none of the dates are, and the only buyable exposure today is a diluted fund position. That is not a criticism of the company; it is just the honest state of play while the parlor game continues.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.